{
  "executiveSummary": "Kent and Ryan, founders of Neuro from Los Angeles, pitched their functional gum and mints designed to boost focus and energy using natural caffeine, L-theanine, and vitamins. They sought $750,000 for 5% equity, highlighting $3.5 million in annual sales and strong retail expansion. Despite multiple offers and positive feedback, they ultimately left without a deal after declining Kevin O’Leary’s royalty offer.",
  "keyDecisions": "No major decisions recorded",
  "actionItems": [
    {
      "task": "Refine retail and marketing strategy to manage growth risks and improve scalability",
      "assignee": "Kent and Ryan",
      "deadline": null,
      "priority": "high"
    },
    {
      "task": "Evaluate distribution partnerships with major airlines like Delta and JetBlue",
      "assignee": "Kent and Ryan",
      "deadline": null,
      "priority": "medium"
    },
    {
      "task": "Continue developing and refining Neuro’s supplement formulations",
      "assignee": "Kent and Ryan",
      "deadline": null,
      "priority": "medium"
    }
  ],
  "nextSteps": "The founders will likely continue scaling Neuro independently, focusing on safe expansion in retail and leveraging their growing consumer base to strengthen their brand without Shark investment.",
  "keyTopics": ["energy supplements", "business valuation", "retail expansion"],
  "sentiment": "positive"
}
